T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to tackle tough blood cancers in young people
Disease control Not yet recruitingThis early-phase study tests a combination of four drugs (venetoclax, dexamethasone, bortezomib, and daratumumab) in 18 adolescents and young adults aged 12–30 whose T-cell acute lymphoblastic leukemia or lymphoma has returned or not responded to prior treatment. The main goal is…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 04:17 UTC
-
Engineered donor cells take aim at hard-to-treat t-cell cancers
Disease control Not yet recruitingThis early-phase trial tests a new treatment for people with T-cell leukemia or lymphoma that has come back. The therapy uses donor T cells that are engineered in a lab to recognize and attack cancer cells carrying a protein called CD7. The study aims to find a safe dose and see …
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 15, 2026 11:53 UTC